01Purpose and principlesWhat the assessment is for and the core concepts behind it.
Choose the test from the mechanism. Chronic or recurrent eczematous dermatitis linked to metals, preservatives, fragrances, rubber or occupation suggests delayed contact allergy and patch testing. Immediate wheal, angioedema, rhinitis, asthma or food-related symptoms may justify targeted prick testing after specialist risk assessment.
Patch panels are applied to normal upper-back skin, retained and read more than once because irritant and allergic patterns evolve differently. Prick testing introduces tiny allergen amounts into superficial skin with histamine and diluent controls; wheal size must be interpreted alongside control validity and pre-test probability.
Patch testing and prick testing distinctions should answer a defined clinical question and be integrated with history, examination and the consequences of error. Explain uncertainty, record the sampling or observation conditions, and arrange a result-review plan rather than treating an isolated finding as self-interpreting.
Key points
- Patch testing evaluates delayed type IV allergic contact dermatitis by applying allergens under occlusion and reading reactions after defined intervals.
- Skin-prick testing evaluates immediate IgE sensitisation within minutes using positive and negative controls in a setting equipped for systemic reactions.
- A positive result shows sensitisation, not automatically clinical allergy; relevance depends on exposure, timing, distribution and symptoms.
- Antihistamines suppress prick-test wheals but generally do not prevent delayed patch reactions; topical corticosteroid at the test site can suppress either local response.
- For Patch testing and prick testing distinctions, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
- A technically adequate result in Patch testing and prick testing distinctions can still be misleading when the wrong lesion, site, preparation or clinical question was selected.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
Eczema developing hours to days after exposure, often on hands, face or contact geometry, supports evaluation for allergic contact dermatitis.
Symptoms beginning within minutes, including wheal, itch, rhinitis or bronchospasm, fit immediate hypersensitivity rather than contact eczema.
Severe back dermatitis or uncontrolled eczema can cause uninterpretable patch responses and may require stabilisation before testing.
Previous severe immediate reactions require specialist planning and resuscitation readiness before any provocation or skin test.
Products, gloves, adhesives and safety-data ingredients should be mapped against work timing and affected anatomical sites.
03Method and interpretationA systematic approach to the test and its findings.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Patch testing with delayed readingsFirst step - Why
- Identify contact sensitisation relevant to chronic eczematous disease.
- Interpretation and limitations
- Morphology and strength at each allergen site are read at protocol-defined times; irritancy, angry-back responses and past sensitisation can confuse relevance.
- 02
Skin-prick testing with controls - Why
- Detect immediate cutaneous sensitisation to selected allergens.
- Interpretation and limitations
- A valid histamine response and negative diluent control are essential; a positive wheal without a compatible history can be clinically irrelevant.
- 03
Exposure inventory and product review - Why
- Connect a positive patch reaction to actual allergen contact.
- Interpretation and limitations
- Inspect complete ingredient names and occupational sources because broad labels such as fragrance-free or hypoallergenic are not sufficient evidence.
- 04
Targeted serum specific IgE - Why
- Provide an alternative when prick testing is unsuitable or unsafe.
- Interpretation and limitations
- Specific IgE also detects sensitisation rather than clinical allergy and should not be ordered as an indiscriminate panel.
04Clinical next stepsHow the result changes management or prompts escalation.
01Planned assessmentUse allergy test selection systematicallyFirst stepThe patient is stable and the result will alter diagnosis, referral or follow-up.+
- 1Define the question for Patch testing and prick testing distinctions, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
- 2Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
- 3Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
02Uncertain resultResolve discordance in Patch testing and prick testing distinctionsThe technical finding conflicts with the history, lesion evolution or wider examination.+
- 1Recheck identity, site, timing, preparation, treatment exposure and whether the selected target was genuinely representative. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
- 2Repeat or select a complementary test only when it can distinguish the remaining important alternatives. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
- 3Seek dermatology, pathology, microbiology or allergy advice when clinicopathological disagreement would change urgent care. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
03Urgent patternDo not let allergy test selection delay escalationEscalationA rapidly progressive eruption, systemic illness, threatened vision or airway, or suspected aggressive malignancy is present. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.+
- 1Stabilise immediate physiological threats and obtain same-day senior or specialty assessment according to the dominant emergency. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
- 2DefinitiveTake time-critical images or specimens only when doing so will not postpone resuscitation, antimicrobials or definitive referral. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
- 3Record evolution and communicate the differential, outstanding results and explicit deterioration triggers during handover. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
- Record who will review the result arising from Patch testing and prick testing distinctions, the expected timescale and the action threshold before the patient leaves.
- Compare subsequent findings with the original site description, dimensions, symptoms and image or specimen identifiers for Patch testing and prick testing distinctions.
- Reassess earlier if rapid growth, bleeding, ulceration, fever, mucosal disease, eye symptoms or functional compromise develops. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
- Document technical limitations and previous treatment that could alter sensitivity or specificity of allergy test selection.
- Close the loop after specialist or laboratory review, including clinicopathological disagreement and any need for repeat sampling. Apply that step specifically within the patch testing and prick testing distinctions assessment and its recorded clinical context.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Mechanism chooses the test
Eczematous delayed reactions and immediate wheal-mediated symptoms require different methods, timing and interpretation.
Controls protect interpretation
A failed histamine control or reactive diluent means a prick panel cannot be read at face value.
Relevance has three times
A patch allergen may explain current disease, only a past reaction, or sensitisation with no demonstrated exposure.
Products hide allergens
Occupational chemicals and personal-care ingredients require exact names, not marketing categories, for avoidance advice.
Testing can provoke symptoms
Prick testing needs trained staff, observation and immediate access to anaphylaxis treatment.
07Common pitfallsFrequent interpretation and management errors.
- 01
Ordering food prick tests for chronic contact-pattern hand eczema without an immediate food-related history.
- 02
Calling every weak patch reaction allergy without considering irritancy, timing and real-world exposure.
- 03
Allowing antihistamine use to invalidate the histamine control during skin-prick testing.
- 04
Performing allergy testing during an acute systemic reaction instead of treating the emergency.
- 05
Giving an avoidance list without checking alternative products, occupational feasibility and hidden synonym names.